Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
220.5 USD | +0.73% | -0.88% | -4.71% |
06/06 | Goldman Sachs Initiates IQVIA With Buy Rating, $270 Price Target | MT |
28/05 | Weight-loss drug forecasts jump to $150 billion as supply grows | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.71% | 4.02TCr | |
+55.55% | 5.93TCr | |
+41.98% | 4.09TCr | |
-5.56% | 2.87TCr | |
+13.76% | 2.66TCr | |
-22.00% | 1.89TCr | |
+31.50% | 1.25TCr | |
+2.16% | 1.24TCr | |
+25.70% | 1.23TCr | |
-6.25% | 1.14TCr |
- Stock Market
- Equities
- IQV Stock
- News Iqvia Holdings Inc.
- IQVIA : UBS Adjusts IQVIA Holdings' Price Target to $275 From $235, Maintains Buy Rating